NCT04526431 - Tacrolimus Pharmacokinetic Subpopulations | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Kidney Transplant Failure and RejectionImmunosuppression-related Infectious Disease

Interventions

DRUG

Dosage Forms Oral

Dosage form of tacrolimus (extended release tacrolimus or immediate release tacrolimus)

Trial Locations (2)

RECRUITING

Grenoble University Hospital, Grenoble

NOT_YET_RECRUITING

Saint Etienne University Hospital, Saint-Etienne